Tikosyn
Atrial Flutter, Atrial Fibrillation, pathologic fistula
Treatment
6 FDA approvals
1 Active Study for Tikosyn
Treatment for
Atrial Flutter
What is Tikosyn
Dofetilide
The Generic name of this drug
Treatment Summary
Dofetilide is a prescription medication that is approved by the FDA to prevent and treat abnormal heart rhythms, such as atrial fibrillation and flutter. It works by restoring the normal beating pattern of the heart.
Tikosyn
is the brand name
Tikosyn Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Tikosyn
Dofetilide
1999
57
Approved as Treatment by the FDA
Dofetilide, otherwise known as Tikosyn, is approved by the FDA for 6 uses including Atrial Fibrillation and symptomatic Atrial flutter .
Atrial Fibrillation
Helps manage symptomatic, recurrent Atrial Fibrillation
symptomatic Atrial flutter
Helps manage symptomatic Atrial flutter
Normal Sinus Rhythm
symptomatic, recurrent Atrial Fibrillation
Helps manage symptomatic, recurrent Atrial Fibrillation
Atrial Flutter
Helps manage symptomatic Atrial flutter
pathologic fistula
Effectiveness
How Tikosyn Affects Patients
Dofetilide is a drug used to treat abnormal heart rhythms. It works by blocking a certain potassium channel, thus slowing down the rate of the heart. It does not affect sodium channels or the adrenergic alpha or beta receptors.
How Tikosyn works in the body
Dofetilide works by blocking potassium channels in the heart. This makes it harder for electrical signals to move through the heart, which prevents the heartbeat from becoming too fast. It also prolongs the amount of time it takes for electrical signals to move through accessory pathways in the heart.
When to interrupt dosage
The suggested dosage of Tikosyn is reliant upon the diagnosed state, including pathologic fistula, Atrial Fibrillation and Atrial Flutter. The amount of dosage is contingent upon the technique of administration as outlined in the table beneath.
Condition
Dosage
Administration
Atrial Fibrillation
0.125 mg, , 0.25 mg, 0.5 mg
Oral, , Capsule - Oral, Capsule
Atrial Flutter
0.125 mg, , 0.25 mg, 0.5 mg
Oral, , Capsule - Oral, Capsule
pathologic fistula
0.125 mg, , 0.25 mg, 0.5 mg
Oral, , Capsule - Oral, Capsule
Warnings
There are 20 known major drug interactions with Tikosyn.
Common Tikosyn Drug Interactions
Drug Name
Risk Level
Description
Anagrelide
Major
The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Anagrelide.
Arsenic trioxide
Major
The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Arsenic trioxide.
Artemether
Major
The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Artemether.
Asenapine
Major
The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Asenapine.
Cisapride
Major
The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Cisapride.
Tikosyn Novel Uses: Which Conditions Have a Clinical Trial Featuring Tikosyn?
An ongoing investigation is assessing the effectiveness of Tikosyn in providing relief from Atrial Fibrillation, pathologic fistulae and Atrial Flutter.
Condition
Clinical Trials
Trial Phases
Atrial Flutter
0 Actively Recruiting
pathologic fistula
0 Actively Recruiting
Atrial Fibrillation
1 Actively Recruiting
Not Applicable
Tikosyn Reviews: What are patients saying about Tikosyn?
5
Patient Review
6/28/2016
Tikosyn for Prevention of Recurrent Atrial Fibrillation
5
Patient Review
3/30/2017
Tikosyn for Atrial Fibrillation
5
Patient Review
3/14/2015
Tikosyn for Atrial Fibrillation
5
Patient Review
6/14/2020
Tikosyn for Prevention of Recurrent Atrial Fibrillation
5
Patient Review
7/18/2021
Tikosyn for Atrial Fibrillation
5
Patient Review
11/26/2020
Tikosyn for Atrial Fibrillation
5
Patient Review
1/26/2017
Tikosyn for Atrial Fibrillation
5
Patient Review
1/7/2015
Tikosyn for Atrial Fibrillation
5
Patient Review
6/27/2015
Tikosyn for Atrial Fibrillation
4.7
Patient Review
2/22/2016
Tikosyn for Prevention of Recurrent Atrial Fibrillation
4.3
Patient Review
8/26/2020
Tikosyn for Paroxysmal Supraventricular Tachycardia
3.3
Patient Review
5/29/2016
Tikosyn for Atrial Fibrillation
3.3
Patient Review
9/6/2021
Tikosyn for Paroxysmal Supraventricular Tachycardia
3
Patient Review
9/22/2015
Tikosyn for Atrial Fibrillation
1
Patient Review
12/7/2018
Tikosyn for Atrial Fibrillation
Patient Q&A Section about tikosyn
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is Tikosyn a beta blocker?
"Dofetilide (Tikosyn) is not a beta-blocker. It does not have beta-blocking effects at normal doses."
Answered by AI
What does the drug Tikosyn do?
"This medication is used to treat certain types of serious irregular heartbeat, such as atrial fibrillation/flutter. It is designed to restore normal heart rhythm and maintain a regular, steady heartbeat. Dofetilide is known as an anti-arrhythmic drug."
Answered by AI
Is Tikosyn a high risk medication?
"Approximately 3 times as many female patients as male patients experienced Torsade de Pointes as a result of taking TIKOSYN during the drug's clinical development program."
Answered by AI